ArticleBMC pediatrics2026
Hospitalization outcomes and laboratory correlations in pediatric MIS-C patients: a retrospective cross-sectional study in Tehran, Iran.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultisystem Inflammatory Syndrome in Children (MIS-C) is a severe and potentially fatal condition. This study aimed to evaluate the clinical features and laboratory data of affected children.
methodsThis cross-sectional study was conducted from 2020 to 2021 at a referral center in Tehran, Iran. Patients meeting the MIS-C criteria with initial laboratory parameters, including Alanine Aminotransferase (ALT), lymphocyte count, ferritin, Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), and albumin, were included. The relationships with outcomes such as duration of admission, intensive care unit (ICU) admission, respiratory support, acute kidney injury, and persistent cardiac problems were assessed using independent t-tests, chi-square tests, Pearson correlation coefficient, and logistic regression.
resultsAmong 100 pediatric MIS-C patients, 26 patients require PICU admission. The majority of patients presented with mucocutaneous (85%) and gastrointestinal (83%) symptoms. Ferritin and CRP levels were significantly associated with longer hospital stays (p = 0.001 and p = 0.02, respectively) and the need for respiratory support (p < 0.001, p = 0.003). Ferritin, ESR, and ALT levels were significantly related to the need for PICU admission (p = 0.004, p = 0.002, and p < 0.001). Further analysis revealed significant associations between less commonly studied ratios and clinical outcomes: the CRP/albumin ratio was associated with PICU admission (p < 0.001), hospital duration (p = 0.04), and respiratory support (p < 0.001); ferritin/ESR ratio correlated with PICU admission (p < 0.001) and hospital duration (p < 0.001); and the ALT/Lymphocyte ratio was linked to hospital duration (p < 0.001), though it was not significantly related to PICU admission (p = 0.36) or respiratory support (p = 0.77).
conclusionKey laboratory markers and ratios are associated with disease severity in MIS-C, aiding in identifying high-risk patients and guiding treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.